References

1. Steven G. Gabbe, Jennifer R. Niebyl and Joe Leigh Simpson. Normal and problem pregnancies. 373; 4^th
2. Norman M, Ekman G and MalmstormA Prostaglandin E₂ – Induced ripening of the human cervix involves changes in prosteoglycan metabolism. Gynecol. 1993; 82:1013-20.
3. Sanchez- Ramos L, Kaunitz AN, Del Valle GO et al. Labor induction with prostaglandin E1 methyl analogmisoprostal vs. oxytocin: A randomized trial. Gynecol. 1993: 81: 332-336.
4. Sherbiny MTE, Gharieb IHEL, Gewely HA. Vaginal misoprostol for induction of labor: 25 vs. 50 µg dose regimen. International Journal of Gynaecology and Obstetrics. 2001; 72:25-30.
5. Karim SMM and Sharma SD. Therapeutic Abortion and Induction of Labor by the Intravaginal Administration of Prostaglandins. The Journal of Obs. and Gyn. of the Brit. Cwlth. 1971; 78:294-300.
6. Nelson GH and Bryans CI. A comparison of oral prostaglandins E₂ and intravenous oxytocin for induction of labor in normal and high risk pregnancies. Am J Obstet& Gynecol1976; 126(5):549-554.
7. Rajan R, Kumari A and Molykutty T. Elective Induction of labor by forewater amniotomy. Journal of obs. and gyn. ogind. 1983:33(6); 760-65.
8. Johnson IR, Macpherson, Welch CC and Filshie GM. A Comparison of Lamycel and Prostaglandin E₂ Vaginal gel for cervical ripening before induction of labor. Am J Obstet Gynecol1985; 151(5):604-7.
9. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2012. Natl Vital Stat Rep. 2013; 62(3):1–20.
10. Gemzell-Danielsson K, Marions L, Rodriguez A, et al.Comparison between oral and vaginal administration of misoprostol on uterine contractility. Obstet Gynaecol, 1999; 93: 275 -280
11. US food and Drug Administration. Full revised misoprostol (Cyto-tec) label – Searle. 2002. Available from: www.accessdata.fda.gov/drugsatfda_docs/label/2002/19268slr037.pdf. Accessed November18, 2014.
12. Fletcher HM. Intravaginal Misoprostol as a Cervical Ripening Agent. BJOG 1993; 100:641-44.
13. Beigi A, Kabiri M and Zarrinkoub F. Cervical ripening with oral misoprostol at term. International journal of Gynaecology and Obstetrics 2003; 83:251-255.
14. Ramsey PS, Harris DY, Ogburn PL Jr, Heise RH, Magtibay PM, Ramdin KD. Division of maternal-fetal medicine. Am J ObstetGynecol 2003; 188(2):560-5.
15. Langenegger EJ, Grove OD. Oral misopr-ostol verses intracervical dinoprostone for induction of labor. International journal of Gynaecology and Obstetrics 2005; 88:242-248.
16. Wing DA, Jones MM, Rahall A, Goodwin TM, Paul RH. A comparison of misoprostol and prostaglandin E₂ gel for pre-induction cervical ripening and labor induction. Am J Obstet&Gynecol 1995; 172(6):1804-10.
17. Danielian P, Porter B, Ferri N, Summers J and Templeton A. Misoprostol for induction of labor at term: A more effective agent than dinoprostone vaginal gel. British Journal of Obstetrics and Gynecology. 1999; 106:793-797.
18. Bartha JL, Comino-Delgado R, Garcia-Benasach F, Martinez-Del-Fresno P, Moreno-Corral LJ. Oral misoprostol and intracervical dinoprostone for cervical ripening and labor induction: A randomized comparison. Gyneco. 2000; 96(3):465-469.
19. Gemund VN, Scherjon S, Cessie S le, Leeuwen JHS, Roosmalen JV and Kanhai HHH. A randomized trial comparing low dose vaginal misoprostol and dinoprostone for labor induction. Br J ObstetGynaecol 2004; 111:42–49.
20. Shetty A, Livingstone I, Rice P, Acharya S, Danielian P and Templeton A. A randomized comparison of oral misoprostol and vaginal prostaglandin E₂ tablets in labor induction at term. International journal of Obstetrics and Gynaecology. 2004; 111:436-440.
21. Baruah J, Das GC and Roy KK. A comparison between intravaginal misoprostol and intra-cervical PGE₂ for induction of labor – A clinical study in Indian women. International Journal of Gynecology and Obstetrics India 2005; 8(5):57-61.
22. Mahajan M, Gupta KB, Sharma, R and Dogra P Comparative study of induction of labor by sublingual misoprostol with dinoprostone gel. Journal of Paediatrics, Obstetrics & Gynaecology 2010; 1(7):272-76.
23. Roux PA le, Olarogun JO, Penny J and Anthony J. Oral and vaginal misoprostol compared with dinoprostone for induction of labor: A randomized controlled trial. Obstetrics & Gynecology. 2002; 81(2):201-04.
24. Garlan SJ, Blust D and O’Brien W. Safety and efficacy of Misoprostol orally and vaginally: A randomized trial. Obstetrics and Gynaecology. 2001; 98(1):107-112.
25. Ramos LS, Kaunitz M and Delke I. Labor induction with 25 micrograms verses 50 micrograms intravaginal misoprostol: A systematic review. Obstetrics and Gynaecology. 2002; 99(1):145-151.
26. Bartusevicius A, Barcaite E and Nadisauskiene R. Oral, vaginal and sublingual misoprostol for induction of labor. International Journal of Gynaecology and Obstetrics 2005; 91:2-9.
27. Lokugamage AU, Forsyth SF, Sullivan KR, Refaey HE and Rodeck CH. Dinoprostrone verses misoprostol: A randomized study of nulliparous women undergoing induction of labor. Obstet. Gynecol. Scand. 2003; 82:133-137.
28. Wing DA, Ham D and Paul RH. A comparison of orally administered misoprostol with vaginally administered misoprostol for cervical ripening and labor induction. Am J Obstel& Gynecol. 1999; 180(5):1155-60.
29. Wing DA, Park MR and Paul RH. A randomized comparison of oral and intravaginal misoprostol for labor induction. Obstet Gynecol. 2000; 95(6):905-08.
30. Bartusevicius A, Barcaite E, Krikstolaitis R, Gintautas V and Nadisauskiene R. Sublingual compared with vaginal misoprostol for labor induction at term: A randomized controlled trial. BJOG 2006; 113:1431-1437.
31. Feitosa FEL, Sampalo ZS, Alencar CA, Amori MMR, Passini R. Sublingual versus vaginal misoprostol for induction of labor. International journal of Gynaecology and Obstetrics 2006; 94:1012-1021.
32. Shetty A, Martin R, Danielian P and Templeton A. A comparison of two dosage regimens of oral misoprostrol for labor induction at term. ActaobstetGynecol Scand. 2002; 81:337-342.
33. Shetty A, Danielian P and Templeton A. Sublingual misoprostol for induction of labor at term. Am J ObstetGynecol 2002; 186(1):72-76.
34. Casterneda CS, Puente JCI, Ochoa RALO, Plasse TF, Powers BL and Rayburn WF. Misoprostol dose selection in a controlled-release vaginal insert for induction of labor in nulliparous women. Am J ObstetGynecol2005; 193:1071-1075.
35. Stephenson ML, Powers BL, Wing DA. Fetal heart rate and cardiotoco­graphic abnormalities with varying dose misoprostol vaginal inserts. J MaternFetal Neonatal Med. 2013; 26(2):127–131.
36. Wing DA, Brown R, Plante LA, Miller H, Rugarn O, Powers BL. Misoprostol vaginal insert and time to vaginal delivery: A randomized controlled trial. Obstet Gynecol. 2013; 122(2 Pt 1):201–209.
37. Souza ASR, Feitosa FEL and Costa, AAR Titrated oral misoprostol solution versus vaginal misoprostol for labour induction. International Journal of Gynaecology Obstetrics India Volume 16 No.:6, 432-437.
38. Deshmukh VL, Aporva V and Ylelikar RKA Oral Misoprostol solution for induction of labor. The Journal of Obstetrics and Gynaecology of India 2017; 67 (2):98-103.
39. Plaut MM, Schwartz ML and Lubarsky SL. Am J Obstet&Gynecol 1999; 180(6):1535-42.
40. Majoko F, Magwali T, Zwizwai M Uterine rupture associated with use of misoprostol for induction of labor. International journal of gynaecology and obstetrics. 2002; 76:77-78.
41. Hofmeyr GJ, Gulmezoglu AM Vaginal misoprostol for cervical ripening and induction of labor in late pregnancy. The Cochrane Library, 2001:2

Corresponding Author

Mahajan M

M.S. (OBG) Government Civil Hospital, Theog, District Shimla, Himachal Pradesh

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.